by NanoVation | Oct 4, 2024 | 2024, Events
Event NVTx leaders featured in ETPN webinar on next-generation LNP technologies NanoVation TherapeuticsTM co-founders Drs Pieter Cullis and Dominik Witzigmann were among the featured speakers in the webinar “Next Generation LNP Technologies for Extra-Hepatic...
by NanoVation | Sep 18, 2024 | 2024, News
News NanoVation Therapeutics announces multi-target partnership with Novo Nordisk to develop genetic medicines targeting cardiometabolic and rare diseases NanoVation will receive research funding and is eligible to receive up to approximately US$600 million in...
by NanoVation | Aug 14, 2024 | 2024, Events
Event NanoVation CSO featured on BIO Podcast NanoVation Co-founder and CSO Dr. Jayesh Kulkarni was interviewed for the BIO Podcast at the BIO International Convention in San Diego, USA, in June 2024. He also spoke at the event on the topic “Exploring the Future...
by NanoVation | Aug 13, 2024 | 2024, 2024, News, Publications
Publication NTx chemistry team publishes in J. of Organic Chemistry Claisen Self-Condensation of Lactones in the Synthesis of Ionizable Lipids Nabi et al. 13 August 2024 Co-authored by NanoVation’s Ardalan Nabi, N. D. Prasad Atmuri, Deaglan Arnold, Fariba Saadati, Huy...
by NanoVation | Aug 3, 2024 | 2024, Events
Event NanoVation CEO interviewed @ Applied Biophysics Forum NanoVation Co-founder and CEO Dominik Witzigmann was interviewed on-site at the Applied Biophysics Forum in Drug Delivery in Copenhagen, Denmark, in May 2024. Dr. Witzimann was also a speaker at the event,...
